What Caught Our Attention: A previous collaborator with high-profile plant biologist Olivier Voinnet (who now has eight retractions) has issued an interesting correction to a 2010 PNAS paper. Susana Rivas is last author on the paper, the correction for which notes some images were duplicated, and others were “cropped and/or stretched to match the other blots.” Rivas is currently a group leader at The Laboratory of Plant-Microbe Interactions (LIPM), “a combined INRA-CNRS Research Unit.” Continue reading Caught Our Notice: Voinnet co-author issues another correction
Why one journal will no longer accept author-suggested reviewers
In a recent editorial, the Journal of Neurochemistry declared it would no longer accept author-suggested reviewers. While other journals have done the same in order to prevent fake reviews, the Journal of Neurochemistry is basing its decision on a different logic. We spoke with editor Jörg Schulz about why he believes relying on reviewers picked by editors helps reduce bias in the peer-review process.
Retraction Watch: What prompted you to compare the outcomes of papers reviewed by experts suggested by authors versus experts selected by editors, or experts the authors “opposed?”
Continue reading Why one journal will no longer accept author-suggested reviewers
“The ‘1’ key was not pressed hard enough:” Did a typo kill a cancer paper?
Errors in a 2017 paper about a new cancer test may have occurred because of a simple typo while performing calculations of the tool’s effectiveness.
According to the last author, the “1” key was likely not pressed hard enough.
The error, however small, affected key values “so greatly that the conclusions of the paper can no longer be supported,” the editor said, which prompted the journal to retract the paper. Continue reading “The ‘1’ key was not pressed hard enough:” Did a typo kill a cancer paper?
Cancer biologist retracts five papers

A cancer researcher based at The Ohio State University has retracted five papers from one journal, citing concerns about figures.
The notices for all five papers state the Journal of Biological Chemistry raised questions about some figures, and the authors were not able to supply raw data in all instances. Four of the notices say the authors offered to submit data from repeat experiments and corrected figures, which the journal declined.
According to Kaoru Sakabe, data integrity manager at JBC, the authors “agreed to withdraw these articles after we declined their offers.”
Stem cell researchers investigated for misconduct recommended for roles at Italy’s NIH

Two stem cell scientists who left Harvard University in the aftermath of a messy misconduct investigation may have found new roles in Italy’s National Institute of Health.
According to a document on the institute’s website, which we had translated, Piero Anversa and Annarosa Leri have been approved to start work at the Istituto Superiore di Sanità (ISS) by the institute’s board of directors. However, the president of the organization told us that the hirings are not yet final.
The document says the board unanimously recommended the appointments of Anversa and Leri on January 31 as winning candidates with “a rating of ‘excellent.’”
According to the document, Anversa would be an ISS expert in stem cell-based treatments for diabetes and Leri would be an expert in stem-based therapies for cardiovascular disease.
However, ISS president Gualtiero Ricciardi told Retraction Watch: Continue reading Stem cell researchers investigated for misconduct recommended for roles at Italy’s NIH
Journals retract 30 papers by engineer in South Korea
An engineer in South Korea has lost 30 papers, at least seven of which for duplication and plagiarism. He has also been fired from his university position.
Soon-Gi Shin, whose affiliation was listed as Kangwon National University in Gangwon, is the sole author on the majority of the papers, published in four journals between 2000 and 2015.
Taewan Kim, the dean of international affairs at the university, told Retraction Watch that Shin was fired on August 21, 2017, over “violation[s] of research ethics.”
Continue reading Journals retract 30 papers by engineer in South Korea
The retraction process needs work. Is there a better way?

Retractions take too long, carry too much of a stigma, and often provide too little information about what went wrong. Many people agree there’s a problem, but often can’t concur on how to address it. In one attempt, a group of experts — including our co-founder Ivan Oransky — convened at Stanford University in December 2016 to discuss better ways to address problems in the scientific record. Specifically, they explored which formats journals should adopt when publishing article amendments — such as corrections or retractions. Although the group didn’t come to a unanimous consensus (what group does?), workshop leader Daniele Fanelli (now at the London School of Economics) and two co-authors (John Ioannidis and Steven Goodman at Stanford) published a new proposal for how to classify different types of retractions. We spoke to Fanelli about the new “taxonomy,” and why not everyone is on board.
Retraction Watch: What do you think are the biggest issues in how the publishing industry deals with article amendments?
Continue reading The retraction process needs work. Is there a better way?
Misconduct investigation reports are uneven at best. Here’s how to make them better.
Retraction Watch readers may have noticed that over the past year or so, we have been making an effort to obtain and publish reports about institutional investigations into misconduct. That’s led to posts such as one about a case at the University of Colorado, Denver, one about the case of Frank Sauer, formerly of the University of California, Riverside, and this story on a case out of the University of Florida.
We’ve obtained the dozen-plus reports we’ve published so far by a variety of means, from public records requests to court documents to old-fashioned leaks. Reading these reports confirms what others — including the Office of Inspector General of the U.S. National Science Foundation — have found. Namely, the reports — which are subject to an inherent conflict of interest, given that institutions are investigating their own — are uneven at best.
We’d like to do something about that. Continue reading Misconduct investigation reports are uneven at best. Here’s how to make them better.
Ethics, authorship concerns sink homeopathy paper by researchers arrested last year
For a host of reasons, a journal has retracted a paper co-authored by a researcher who reportedly once faced charges of practicing medicine without proper qualifications.
According to the retraction notice for “Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study,” published Dec. 8, 2010 in Evidence-Based Complementary and Alternative Medicine, the paper was plagued by:
Continue reading Ethics, authorship concerns sink homeopathy paper by researchers arrested last year
Weekend reads: A new plagiarism euphemism; how Photoshop abuse destroys science; bias against women authors
The week at Retraction Watch featured a look at what happens to authors when a journal is delisted, a reminder of how hard it is to figure out whether a paper has been retracted, and a survey on how common plagiarism is in economics. Here’s what was happening elsewhere: Continue reading Weekend reads: A new plagiarism euphemism; how Photoshop abuse destroys science; bias against women authors